Clinical Trial Update: Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 studies evaluating the safety and efficacy of liposomal latanoprost for ocular hypertension have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension

Drugs mentioned

• Liposomal latanoprost (latanoprost liposome formulation)

Snippet

Sponsor: Singapore Eye Research Institute | Conditions: Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED